How Much Does Longevity Testing Cost? Handling the Price Question on the First Call

A prospect has spent three weeks reading about longevity medicine. He has seen direct-to-consumer home biomarker kits priced in the low hundreds and he has seen clinic memberships priced in five figures. He does not understand the gap, so he calls and asks the only question he knows how to ask.

The gap is real and it is documented. Fountain Life lists its APEX membership at $21,500. Biograph sells Core at $7,500 and Black at $15,000. Cenegenics prices its Performance Health Assessment between $4,495 and $13,000 with prescriptions billed monthly on top. Next Health charges $299 a month for membership with a 500-plus biomarker package at $2,999. Four clinics, four structures, one caller with no way to compare them.

If the front desk quotes a number cold, or sends him to voicemail, the clinic loses a member who would have paid. Not because the price was wrong, but because nobody connected the price to anything.

Longevity intake starts at price because price is the only thing the caller can find and the one thing he cannot interpret

The four structures above are not four versions of one product. Fountain Life's APEX is an annual membership. Cenegenics sells a one-time assessment and bills prescriptions separately on top of it. Next Health separates a monthly membership from a biomarker package that can be bought on its own. Biograph sells tiers. A caller weighing $299 a month against $21,500 a year is not comparing two prices. He is comparing four different definitions of what he would be buying, and nothing on any of those pages tells him which definition applies to him.

So he calls. And the first ninety seconds of that call decide whether he books a consult or keeps shopping.

Price is the symptom. The missing value translation is the disease

A longevity program is not bought on price. It is bought on understood value - the clinician time, the longitudinal tracking, the protocol that the baseline panel exists to inform. When the first call cannot connect the panel cost to the program it opens, the prospect anchors on the sticker and leaves. The number was not the objection. The unanswered "what do I actually get for this" was. This is the same translation gap that shows up when a caller cannot name the program they want - surfacing here as price instead of vocabulary.

The first call has to translate the panel into what it rules out, not defend the number

Part of the answer to "why does it cost that" is that the guidelines require the repeat draw. The Endocrine Society's clinical practice guideline on testosterone therapy in men with hypogonadism (Bhasin et al., Journal of Clinical Endocrinology and Metabolism 2018;103(5):1715-1744) calls for diagnosis on the basis of two separate early-morning fasting total testosterone measurements, not one. The American Urological Association's Testosterone Deficiency Guideline, issued in 2018 and confirmed for validity in 2024, sets the same two-measurement requirement. A single hormone marker done to guideline is two draws on two mornings plus clinician interpretation. Multiply that across a full panel and the number stops looking arbitrary.

That is what the first call has to convey. Concretely, it has to:

• Answer every time, including after hours. It does not send a high-intent prospect to voicemail, because these callers are comparison-shopping in the evening after work.

• Capture the prospect's actual goal - energy, hormones, healthspan, a specific worry - before any number is discussed, so the price lands inside a reason rather than in a vacuum.

• Frame the panel as the entry point to a program, not a standalone charge: the baseline informs the membership, and the membership is where the recurring relationship and the value live.

• Move quickly. These prospects evaluate two or three clinics at once. The first one to give a clear, calm value frame and a booked consult usually wins the member.

The stakes are not small. On published pricing, the recurring membership programs named above span roughly $3,600 a year at Next Health's $299 monthly rate, $7,500 and $15,000 a year for Biograph's Core and Black tiers, and $21,500 a year for Fountain Life's APEX. Cenegenics sits outside that recurring band: its $4,495 to $13,000 Performance Health Assessment is a one-time assessment fee, with prescriptions billed separately on top. Losing a converted member to a fumbled price call is not a rounding error. It is a year of program revenue walking to a competitor who answered the phone better. This is why we treat the first call as infrastructure, not luck, and it is the same first-contact economics behind the lifetime value lost on a single missed first call.

This frees your concierge team, it does not replace them

The structured intake layer handles first-touch capture and the value framing so your human concierge or clinician spends time on the qualified prospect who is ready to talk protocol - not on triaging price questions at the front desk all day. The layer makes sure high-intent callers are not lost or mishandled before a person takes over the relationship. It is amplification of your team, not a substitute for the human judgment a longevity consult depends on. This is the work Aurora, our vitality specialist, is built around.

A better call names the biomarkers, the guideline behind them, and what changes if a result comes back abnormal

The difference is not a script that dodges the price. It is a first call that says, in effect: tell me what brought you in, here is what the baseline panel measures and why it costs what it does, here is the program it feeds, and here is a consult where a clinician walks you through your own numbers.

Naming the markers helps - total and free testosterone, a lipid panel, HbA1c, hs-CRP, thyroid function - and so does naming what happens next. An abnormal hormone result means a second early-morning fasting draw before anything is prescribed, because that is what the Endocrine Society and AUA guidelines call for. A caller who hears that understands he is buying a diagnostic process, not a line item.

The price still gets stated plainly - honesty is the brand - but it lands as the entry to something understood rather than a figure floating alone. A prospect who hears that books a consult. A prospect who hears a five-figure number and nothing else hangs up and dials the next clinic on his list.

References

[1] Fountain Life. APEX membership pricing, published on fountainlife.com.

[2] Biograph. Core and Black membership pricing, published on biograph.com.

[3] Cenegenics. Performance Health Assessment pricing, described as a one-time assessment with prescriptions billed separately, published on cenegenics.com.

[4] Next Health. Membership and biomarker package pricing, published on next-health.com.

[5] Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism. 2018;103(5):1715-1744.

[6] American Urological Association. Testosterone Deficiency Guideline. 2018; validity confirmed 2024. auanet.org

Next Step

If your premium practice runs more than 100 inbound consult inquiries a month and has no structured measurement of how many never reach a scheduled consultation, your pipeline is leaking revenue. We quantify this for your practice in a 30-minute Intake Leak Audit.

• Request an Intake Leak Audit: expand@thethinkingrobot.com

• Audit Real-Time Conversational Velocity: Talk to Rosey, our AI receptionist, at +1 (720) 776-1664.